Literature DB >> 11039334

Vascular compliance in normal pressure hydrocephalus.

G A Bateman1.   

Abstract

BACKGROUND AND
PURPOSE: Normal pressure hydrocephalus (NPH) is considered to be a combination of altered CSF resorption and a reversible form of cerebral ischemia. The hypothesis tested in this study was that a reduction in venous compliance in the territory drained by the superior sagittal sinus (SSS) is associated with NPH and cerebral ischemia.
METHODS: This prospective study involved 27 patients without evidence of hydrocephalus. This group was subdivided into those with normal MR findings and those with evidence of ischemia or atrophy. Ten patients with NPH then underwent MR flow quantification studies of the cerebral vessels. Five of these patients had the same studies performed after CSF drainage. Vascular compliance was measured in the SSS and straight sinus territory by use of MR flow quantification with net systolic pulse volume (NSPV) and arteriovenous delay (AVD) as markers.
RESULTS: Vascular compliance of patients with ischemia or atrophy was significantly higher than that of healthy subjects (mean NSPV in the SSS, 417 microL and 274 microL, respectively). Patients with NPH showed lower compliance than that of the healthy subjects in the SSS (mean NSPV, 212 microL and 274 microL, respectively; mean AVD, 42 ms and 89 ms, respectively). After intervention, the NPH group showed compliance approximating the group with ischemia/atrophy.
CONCLUSION: Vascular compliance is significantly different in the brains of healthy subjects as compared with that in patients with ischemia/atrophy or NPH.

Entities:  

Mesh:

Year:  2000        PMID: 11039334      PMCID: PMC8174849     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Brain edema.

Authors:  R A Fishman
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

2.  The relationship of pulsatile cerebrospinal fluid flow to cerebral blood flow and intracranial pressure: a new theoretical model.

Authors:  M Bergsneider; A A Alwan; L Falkson; E H Rubinstein
Journal:  Acta Neurochir Suppl       Date:  1998

3.  Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study.

Authors:  S Savolainen; L Paljärvi; M Vapalahti
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

4.  Cerebrospinal fluid circulation and associated intracranial dynamics. A radiologic investigation using MR imaging and radionuclide cisternography.

Authors:  D Greitz
Journal:  Acta Radiol Suppl       Date:  1993

Review 5.  A new view on the CSF-circulation with the potential for pharmacological treatment of childhood hydrocephalus.

Authors:  D Greitz; T Greitz; T Hindmarsh
Journal:  Acta Paediatr       Date:  1997-02       Impact factor: 2.299

Review 6.  The anatomy of collateral venous flow from the brain and its value in aetiological interpretation of intracranial pathology.

Authors:  J Andeweg
Journal:  Neuroradiology       Date:  1996-10       Impact factor: 2.804

7.  Cerebrospinal fluid flow measured by phase-contrast cine MR.

Authors:  D R Enzmann; N J Pelc
Journal:  AJNR Am J Neuroradiol       Date:  1993 Nov-Dec       Impact factor: 3.825

8.  Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly.

Authors:  J K Krauss; J P Regel; W Vach; D W Droste; J J Borremans; T Mergner
Journal:  Stroke       Date:  1996-01       Impact factor: 7.914

9.  Cine MR CSF flow study in hydrocephalus: what are the valuable parameters?

Authors:  M H Kim; K M Shin; J H Song
Journal:  Acta Neurochir Suppl       Date:  1998

Review 10.  The predictive value of cerebrospinal fluid dynamic tests in patients with th idiopathic adult hydrocephalus syndrome.

Authors:  J Malm; B Kristensen; T Karlsson; M Fagerlund; J Elfverson; J Ekstedt
Journal:  Arch Neurol       Date:  1995-08
View more
  54 in total

1.  Toward a better understanding of normal pressure hydrocephalus.

Authors:  G A Bateman
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

2.  The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion.

Authors:  G A Bateman
Journal:  Neuroradiology       Date:  2003-01-16       Impact factor: 2.804

3.  Vascular hydraulics associated with idiopathic and secondary intracranial hypertension.

Authors:  Grant A Bateman
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

4.  Ventricular lactate in normal pressure hydrocephalus: from where has it come to where does it go?

Authors:  Grant A Bateman
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

5.  Neocortical capillary flow pulsatility is not elevated in experimental communicating hydrocephalus.

Authors:  Shams Rashid; James P McAllister; Yiting Yu; Mark E Wagshul
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-21       Impact factor: 6.200

6.  The correlations between a proposed pathogenesis of syringomyelia and normal pressure hydrocephalus.

Authors:  Grant A Bateman
Journal:  Neurosurg Rev       Date:  2010-08-17       Impact factor: 3.042

Review 7.  The differential diagnosis and treatment of normal-pressure hydrocephalus.

Authors:  Michael Kiefer; Andreas Unterberg
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

8.  Extending the hydrodynamic hypothesis in chronic hydrocephalus.

Authors:  Grant A Bateman
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

9.  Prediction of the jugular venous waveform using a model of CSF dynamics.

Authors:  J Kim; N A Thacker; P A Bromiley; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

10.  Development of a theoretical framework for analyzing cerebrospinal fluid dynamics.

Authors:  Benjamin Cohen; Abram Voorhees; Søren Vedel; Timothy Wei
Journal:  Cerebrospinal Fluid Res       Date:  2009-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.